Seller record · Research vendor

Pure Rawz

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician, prescriber or medical reviewer is named, and the terms page sends the reader to an outside professional. 3 more criteria also fail; see the table below.

At a glance

Pure RawzResearch vendor

3/8criteria passed

Price: Printed on its own pages before sign-up
FDA letters: 1 on file

No storefront is open to link to.

See all eight dispositions

Research vendor. Passes 3 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

An affiliate website covering peptides, SARMs and other research compounds. It states that it does not sell products directly, and each product page routes the reader to third-party sellers while still printing a price range. An FDA warning letter names the storefront.

Operating entity No legal entity name is printed in the footer of every page, the contact page, the terms and conditions page or the privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Pure Rawz's terms and conditions
S2	Prescription gating	NOT VERIFIED	Pure Rawz's BPC-157 product page
S3	Pharmacy identification	FAIL	Pure Rawz's about page
S4	Compounding disclosure	PASS	Pure Rawz's BPC-157 product page
S5	Analytical documentation	FAIL	Pure Rawz's website
S6	Business address	FAIL	Pure Rawz's terms and conditions
S7	Price disclosure	PASS	Pure Rawz's BPC-157 product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician, prescriber or medical reviewer is named, and the terms page sends the reader to an outside professional.Source: Pure Rawz's terms and conditions.

S2NOT VERIFIEDAn order path did not resolve, because the cart and the checkout both resolve to the homepage. The check is open.Source: Pure Rawz's BPC-157 product page.

S3FAILNo pharmacy is named anywhere on the site, and the about page disclaims all fulfillment and assigns it to third-party websites.Source: Pure Rawz's about page.

S4PASSThe seller offers no compounded drug, and the product page states plainly that the compound is not FDA-approved for human use.Source: Pure Rawz's BPC-157 product page.

S5FAILThe homepage asserts purity in marketing language, and no certificate, chromatogram or lot report appears anywhere on the site.Source: Pure Rawz's website.

S6FAILThe contact page prints an email address and a telephone number, and no street address appears in the footer, terms or privacy policy.Source: Pure Rawz's terms and conditions.

S7PASSThe BPC-157 page prints a visible price range in dollars with no login and no form in the way.Source: Pure Rawz's BPC-157 product page.

S8PASSFDA warning letter 715218, September 2025, names the storefront and alleges its tianeptine products are unapproved new drugs; no FDA action has halted the business, and the seller still operates.Source: FDA warning-letter index.

Enforcement documents on file: 1 warning letter

FDA warning letter 715218, issued September 2025, to PureRawzThe tianeptine products offered from Pure Rawz's website are unapproved new drugs intended for human use, despite labeling marketing them for laboratory and research use only.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.